Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /app/ Disallow: /j/ Allow: /app/module/webproduct/goto/ Allow: /app/download/ Sitemap: |
Title | Home - Invizius - second generation complement therapeutics for autoimmune and inflammatory |
Description | Invizius is developing products to help patients on dialysis, cardiopulmonary bypass, ECMO and on other extra-corporeal treatments, to feel better, and suffer fewer |
Keywords | N/A |
WebSite | invizius.com |
Host IP | 185.60.251.251 |
Location | Germany |
Site | Rank |
US$259,273
Last updated: 2023-04-29 15:09:10
invizius.com has Semrush global rank of 40,823,073. invizius.com has an estimated worth of US$ 259,273, based on its estimated Ads revenue. invizius.com receives approximately 29,917 unique visitors each day. Its web server is located in Germany, with IP address 185.60.251.251. According to SiteAdvisor, invizius.com is safe to visit. |
Purchase/Sale Value | US$259,273 |
Daily Ads Revenue | US$240 |
Monthly Ads Revenue | US$7,180 |
Yearly Ads Revenue | US$86,159 |
Daily Unique Visitors | 1,995 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
invizius.com. | A | 600 | IP: 185.60.251.251 |
invizius.com. | NS | 3600 | NS Record: ns16.domaincontrol.com. |
invizius.com. | NS | 3600 | NS Record: ns15.domaincontrol.com. |
invizius.com. | MX | 3600 | MX Record: 0 invizius-com.mail.protection.outlook.com. |
invizius.com. | TXT | 3600 | TXT Record: MS=ms25564921 |
invizius.com. | TXT | 3600 | TXT Record: google-site-verification=6td6O3DuG9kPVV1WOFQxpW6z-ylagUhxAw0-HIed8Es |
invizius.com. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com include:spf.protection.outlook.com ~all |
About Us Origins Leadership Team Clinical & Scientific Advisors Investors Collaborators Alison Prosser Our Science PspCN Complement Regulator Our Pipeline Clinical Trials Product News & Events Press Releases Events Contact About Us Origins Leadership Team Clinical & Scientific Advisors Investors Collaborators Alison Prosser Our Science PspCN Complement Regulator Our Pipeline Clinical Trials Product News & Events Press Releases Events Contact INVIZIUS Invizius is a clinical stage biotech developing second generation complement therapies to treat inflammatory, fibrotic and autoimmune disorders Our Pipeline > Our proprietary technology harnesses and supercharges natural complement regulators to maximise potential patient safety and clinical efficacy Our Science > Our lead product, H-Guard, is in clinical development and aims to address serious unmet needs for patients on dialysis and other extracorporeal circuit therapies Our Lead Product > Connect with us 2023 © Invizius. All |
HTTP/1.1 301 Moved Permanently Cache-Control: no-cache, no-store, must-revalidate Content-Type: text/html; charset=UTF-8 Date: Fri, 22 Oct 2021 12:57:01 GMT Location: https://www.invizius.com/ Server: nginx X-Jimdo-Instance: i-093cc9273aaff2ab9 X-Jimdo-Wid: sdd4fce2fcc240995 X-RateLimit-Limit: 8000 X-RateLimit-Remaining: 7999 X-RateLimit-Reset: 0 HTTP/1.1 200 OK Date: Fri, 22 Oct 2021 12:57:02 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive Vary: Accept-Encoding X-RateLimit-Limit: 8000 X-RateLimit-Remaining: 7999 X-RateLimit-Reset: 0 X-Jimdo-Instance: i-07c75ec6920d5ee0f X-Jimdo-Wid: sdd4fce2fcc240995 Cache-Control: no-cache, no-store, must-revalidate Strict-Transport-Security: max-age=604800 Server: nginx |
Domain Name: INVIZIUS.COM Registry Domain ID: 2099917088_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-09-06T10:44:50Z Creation Date: 2017-02-23T15:27:43Z Registry Expiry Date: 2025-02-23T15:27:43Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS15.DOMAINCONTROL.COM Name Server: NS16.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T04:08:29Z <<< |